Site icon Drug Trials For Money – Paid Clinical Trials

Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD

Conditions: Chronic Kidney Disease Mineral and Bone Disorder; Hypertension; Diabetes; Dyslipidemia; Atherosclerotic Cardiovascular Disease (ASCVD); Chronic Kidney Disease (Stage 3)
Interventions: Drug: Low-dose Colchicine at 0.5mg daily; Other: Usual Care
Sponsors: University of Texas Southwestern Medical Center
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Exit mobile version